To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/c/newtothestreettv Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet Follow New to the Street on Facebook:...
Acurx Phamaceuticals
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) David Luci, President/CEO.
From the Nasdaq MarketSite Studio, New to The Street's TV Host Jane King talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) ("Company"), a late-stage biopharmaceutical company that publicly...
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) ("Company"), a late-stage biopharmaceutical Company. ACXP is developing...
The Latest News from ACURX Pharma on New to the Street
To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/c/newtothestreettv Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet Follow New to the Street...
ACURX Interview In New to the Street
To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/c/newtothestreettv Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet Follow New to the Street...
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage biopharmaceutical business, ACXP is...
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage biopharmaceutical business, ACXP is developing a...
Biopharmaceutical -Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage biopharmaceutical business, ACXP is developing a...
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for...
Biopharmaceutical – Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President/CEO.
New to The Street's TV Host Jane King from the Nasdaq MarketSite Studio talks with David Luci, the President/CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for...